Gene · 2050
Papers2,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nitric oxide synthase and reduced arterial tone contribute to arteriovenous malformation. | Sci Adv | 2023 | 37235659 | PubTator, text mining | PubMed |
| Effective long-term sirolimus treatment in hypoxemia mainly due to intrapulmonary right-to-left shunt in a patient with multiple vascular anomalies. | Orphanet J Rare Dis | 2023 | 37226169 | PubTator, text mining | PubMed |
| Discovery of intracellular self-assembly protein degraders driven by tumor-specific activatable bioorthogonal reaction. | Eur J Med Chem | 2023 | 37216813 | PubTator, text mining | PubMed |
| Synergistic immunotherapy targeting cancer-associated anemia: prospects of a combination strategy. | Cell Commun Signal | 2023 | 37208766 | PubTator, text mining | PubMed |
| Connexin 37 sequestering of activated-ERK in the cytoplasm promotes p27-mediated endothelial cell cycle arrest. | Life Sci Alliance | 2023 | 37197981 | PubTator, text mining | PubMed |
| Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study. | Circ Heart Fail | 2023 | 37192292 | PubTator, text mining | PubMed |
| Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases. | Cell Commun Signal | 2023 | 37189112 | PubTator, text mining | PubMed |
| Preclinical and Basic Research Strategies for Overcoming Resistance to Targeted Therapies in HER2-Positive Breast Cancer. | Cancers (Basel) | 2023 | 37174034 | PubTator, text mining | PubMed |
| Revisiting the role of mesenchymal stem cells in tuberculosis and other infectious diseases. | Cell Mol Immunol | 2023 | 37173422 | PubTator, text mining | PubMed |
| Angiogenic signaling pathways and anti-angiogenic therapy for cancer. | Signal Transduct Target Ther | 2023 | 37169756 | PubTator, text mining | PubMed |
| Predictive data-driven modeling of C-terminal tyrosine function in the EGFR signaling network. | Life Sci Alliance | 2023 | 37169593 | PubTator, text mining | PubMed |
| A Vascular Quartet: Scalp Arteriovenous Malformation, Sinus Pericranii, Dural Arteriovenous Fistula, and Arteriovenous Brain Malformation in a Single Patient. | Cureus | 2023 | 37153271 | PubTator, text mining | PubMed |
| EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells. | PLoS Pathog | 2023 | 37146061 | PubTator, text mining | PubMed |
| miR-342-5p downstream to Notch enhances arterialization of endothelial cells in response to shear stress by repressing MYC. | Mol Ther Nucleic Acids | 2023 | 37128275 | PubTator, text mining | PubMed |
| The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy. | Exp Mol Med | 2023 | 37121970 | PubTator, text mining | PubMed |
| Reconstruction of the cell pseudo-space from single-cell RNA sequencing data with scSpace. | Nat Commun | 2023 | 37120608 | PubTator, text mining | PubMed |
| Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment. | Pharmaceuticals (Basel) | 2023 | 37111367 | PubTator, text mining | PubMed |
| The Therapeutic Effects of EFNB2-Fc in a Cell Model of Kawasaki Disease. | Pharmaceuticals (Basel) | 2023 | 37111257 | PubTator, text mining | PubMed |
| Novel Isoform DTX3c Associates with UBE2N-UBA1 and Cdc48/p97 as Part of the EphB4 Degradation Complex Regulated by the Autocrine IGF-II/IRA Signal in Malignant Mesothelioma. | Int J Mol Sci | 2023 | 37108544 | PubTator, text mining | PubMed |
| Understanding the Role of Chemerin in the Pathophysiology of Pre-Eclampsia. | Antioxidants (Basel) | 2023 | 37107205 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2050/papers?page=14